Sterile immunogenic non-tumorigenic tumor cell compositions and methods
This invention relates to methods of removing bioburden from an aggregate of cells to obtain sterile cells that remain viable and immunogenic for the production of vaccines. This invention further relates to a method of eliciting an immune response to prevent a recurrence of metastases that involves...
Saved in:
Main Authors | , , |
---|---|
Format | Patent |
Language | English |
Published |
08.12.2009
|
Online Access | Get full text |
Cover
Loading…
Abstract | This invention relates to methods of removing bioburden from an aggregate of cells to obtain sterile cells that remain viable and immunogenic for the production of vaccines. This invention further relates to a method of eliciting an immune response to prevent a recurrence of metastases that involves preparing and administering a sterile vaccine derived from solid tumors. The vaccine is prepared by excising a solid tumor from a cancer patient, digesting the tumor cells with an enzyme to obtain dissociated cells, irradiating the dissociated cells to render the cells non-tumorigenic, and sterilizing the cells. |
---|---|
AbstractList | This invention relates to methods of removing bioburden from an aggregate of cells to obtain sterile cells that remain viable and immunogenic for the production of vaccines. This invention further relates to a method of eliciting an immune response to prevent a recurrence of metastases that involves preparing and administering a sterile vaccine derived from solid tumors. The vaccine is prepared by excising a solid tumor from a cancer patient, digesting the tumor cells with an enzyme to obtain dissociated cells, irradiating the dissociated cells to render the cells non-tumorigenic, and sterilizing the cells. |
Author | Haspel, Martin V Hanna, Jr, Michael G Pomato, Nicholas |
Author_xml | – sequence: 1 givenname: Martin V surname: Haspel fullname: Haspel, Martin V – sequence: 2 givenname: Nicholas surname: Pomato fullname: Pomato, Nicholas – sequence: 3 givenname: Michael G surname: Hanna, Jr fullname: Hanna, Jr, Michael G |
BookMark | eNqNiksOwjAMBbOARfncwReohEAqdI0o7GGPotS0lhK7ip378z0Aq3mjNws3Y2Gs3PlqmCkiUEqFZUCmAK-rtpIk09c_GwLGCEHSJEpGwgqee0hoo_S6cvOHj4rrH5cOutPteKmLTt6QTe9D9m9s9s320LbN7o_kCbdYN44 |
ContentType | Patent |
CorporateAuthor | Intracel Resources LLC |
CorporateAuthor_xml | – name: Intracel Resources LLC |
DBID | EFH |
DatabaseName | USPTO Issued Patents |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EFH name: USPTO Issued Patents url: http://www.uspto.gov/patft/index.html sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
ExternalDocumentID | 07628996 |
GroupedDBID | EFH |
ID | FETCH-uspatents_grants_076289963 |
IEDL.DBID | EFH |
IngestDate | Sun Mar 05 22:31:02 EST 2023 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-uspatents_grants_076289963 |
OpenAccessLink | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7628996 |
ParticipantIDs | uspatents_grants_07628996 |
PatentNumber | 7628996 |
PublicationCentury | 2000 |
PublicationDate | 20091208 |
PublicationDateYYYYMMDD | 2009-12-08 |
PublicationDate_xml | – month: 12 year: 2009 text: 20091208 day: 08 |
PublicationDecade | 2000 |
PublicationYear | 2009 |
References | Berd (6333028) 20011200 Margolis-Nunno et al. (6413714) 20020700 Harris, J.E., "Adjuvant Active Specific Immunotherapy for Stage II and III Colon Cancer with an Autologous Tumor Cell Vaccine: Eastern Cooperative Oncology Group Study E5283", Journal of Clinical Oncology, vol. 18, No. 1, Jan. 2000, pp. 148-157. Hanna MG Jr, Peters LC, Hoover HC Jr., "Immunotherapy by active specific immunization: Basic Principles and Preclinical Studies", Biologic Therapy of Cancer Principles and Preclinical Studies, pp. 651-669, 1991. Hoover HC Jr, Surdyke MG, Dangel RB, et al., "Prospectively randomized trial of adjuvant active specific immunotherapy for human colorectal cancer", Cancer 55:1236-1243, Mar. 1985. Hanna MG Jr, Peters LC., "Specific immunotherapy of established visceral micrometastases by BCG-tumor cell vaccine alone or as an adjunct to surgery", Cancer 42:2613-2625, Dec. 1978. Hanna MG Jr, Peters LC., "Morphological and functional aspects of active specific immunotherapy of established pulmonary metastases in guinea pigs", Cancer Res 41:4001-4009, Oct. 1981. Smilowitz et al. (6299873) 20011000 Wood (6406699) 20020600 Peterson (5730933) 19980300 Hanna MG Jr, Zbar B, Rapp HJ., "Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis," J Natl Cancer Inst 48:1441-1455, May 1972. Peters LC, Hanna MG Jr., "Active specific immunotherapy of established micrometastasis: Effect of cryopreservation Procedures on Tumor Cell Immunogenicity in Guinea Pigs", J Natl Cancer Inst 64:1521-1525, Jun. 1980. Hanna MG Jr, Peters LC., "Immunotherapy of established micrometastases with bacillus calmette-guérin tumor cell vaccine", Cancer Res 38:204-209, Jan. 1978. Granger (5837233) 19981100 Peters, L.C. et al., "Preparation of Immunotherapeutic Autologous Tumor Cell Vaccines from Solid Tumors", Cancer Research, vol. 39, Apr. 1979, pp. 1353-1360. Hanna, Jr. et al. (5484596) 19960100 Dalmasso et al. (5788941) 19980800 Hanna MG Jr, Snodgrass MJ, Zbar B, Rapp HJ., "Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and to BCG", J Natl Cancer Inst 51:1897-1908, Dec. 1973. Holler (5532141) 19960700 Examination Report issued Jun. 26, 2007. Ravindranath et al. (6218166) 20010400 Hanna MG Jr, Peters LC., "Efficacy of intralesional BCG therapy in guinea pigs with disseminated tumor", Cancer 36:1298-1304, Oct. 1975. (0151030) 19850800 Granger (6136306) 20001000 Hrinda et al. (5300433) 19940400 Laugharn, Jr. et al. (6270723) 20010800 Girardot et al. (6506339) 20030100 Hanna MG Jr, Peters LC, Fidler IJ, "The efficacy of BCG-induced tumor immunity in guinea pigs with regional and systemic malignancy", Cancer Immunol Immunother 1:171-177, 1976. Janicke et al (1994), Cancer Research, vol. 54, pp. 2527-2530. Hoover HC Jr, Surdyke M, Dangel RB, et al., "Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer patients immunized with an autologous tumor cell: Bacillus Calmette-Guérin vaccine", Cancer Res 44:1671-1676, Apr. 1984. Maes (6090385) 20000700 Hanna, M.G. Jr., "Adjuvant Active Specific Immunotherapy of Stage II and III Colon Cancer with an Autologous Tumor Cell Vaccine: First Randomized Phase III Trials Show Promise", Vaccine, vol. 19, No. 17-19, Mar. 2001, pp. 2576-2582. Hamer et al (1999), J Bone Joint Surg [Br], 81-B, pp. 342-344. Young et al. (6180357) 20010100 Dalgleish et al. (6699483) 20040300 Hanna MG Jr, Brandhorst JS, Peters LC., "Active specific immunotherapy of residual micrometastasis: An evaluation of sources, doses and ratios of BCG with tumor cells", Cancer Immunol Immunother 7:165-173, 1979. Definition of "excision" in Merriam-Webster Online Dictionary downloaded on Jan. 30, 2007 from the url, world wide web, m-w.com. Judy et al. (4878891) 19891100 (WO 93/06867) 19930400 Peters LC, Brandhorst JS, Hanna MG Jr., "Preparation of immunotherapeutic autologous tumor cell vaccines from solid tumors", Cancer Res 39:1353-1360, Apr. 1979. |
References_xml | – year: 19891100 ident: 4878891 contributor: fullname: Judy et al. – year: 19930400 ident: WO 93/06867 – year: 19960100 ident: 5484596 contributor: fullname: Hanna, Jr. et al. – year: 19980300 ident: 5730933 contributor: fullname: Peterson – year: 19850800 ident: 0151030 – year: 20040300 ident: 6699483 contributor: fullname: Dalgleish et al. – year: 20020700 ident: 6413714 contributor: fullname: Margolis-Nunno et al. – year: 19981100 ident: 5837233 contributor: fullname: Granger – year: 20020600 ident: 6406699 contributor: fullname: Wood – year: 19940400 ident: 5300433 contributor: fullname: Hrinda et al. – year: 20010100 ident: 6180357 contributor: fullname: Young et al. – year: 20011200 ident: 6333028 contributor: fullname: Berd – year: 20011000 ident: 6299873 contributor: fullname: Smilowitz et al. – year: 19960700 ident: 5532141 contributor: fullname: Holler – year: 20010400 ident: 6218166 contributor: fullname: Ravindranath et al. – year: 19980800 ident: 5788941 contributor: fullname: Dalmasso et al. – year: 20010800 ident: 6270723 contributor: fullname: Laugharn, Jr. et al. – year: 20001000 ident: 6136306 contributor: fullname: Granger – year: 20000700 ident: 6090385 contributor: fullname: Maes – year: 20030100 ident: 6506339 contributor: fullname: Girardot et al. |
Score | 2.752427 |
Snippet | This invention relates to methods of removing bioburden from an aggregate of cells to obtain sterile cells that remain viable and immunogenic for the... |
SourceID | uspatents |
SourceType | Open Access Repository |
Title | Sterile immunogenic non-tumorigenic tumor cell compositions and methods |
URI | https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7628996 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEB7aItSeFC3WFzl4ja77SNdz6boISkGF3kqyOy2Fdrd0s_TvO5OtpRe95QGTkGGSmfDNNwAPmrQcZKjkXOtMhipEaZQiR873zdB4Eb64PO73D5V-h2_TaNqC9JALsyYzkhvaS_VYVxtbOnAlXe-N4mVD_swcgQWzD-yKVanzST5_IqOm0EG1oR17DO0aJ2kPuiSCXLbCVkePRnIGJxM3eg4tLC7g9ZNpkVcolpySUZLilpmg4Fvaes3lqVzftQX_pgsGe_8iqgTF-6Ip9lxdgkjGX6NUHladLbaMZpl5-90FfeiQYLwCgfFQR0gmjmjC-Jk8IaYI9vNAYcBeyQAGf4q5_mfuBk79fYkDL76Fjt3WeEfvpjX37lB-AC6feiY |
link.rule.ids | 230,309,786,808,891,64396 |
linkProvider | USPTO |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT8MwDLbGQDxOIECMZw5cA6WPrJxhpbymSoC0W9W0Hpq0tdOair-PnY6JC9zykJwojmM7sj8DXGbEZS9HJcdZlktf-Si1UmTIua7uayfAW5vH_TpU8Yf_NApGHYhXuTAzEiM5p73UV009N5UNrqTnvWW8bMGfGSOwZPSBr3JaZUVSjK9JqMl1UGuwzjqW7_ogindgi4iQ0Vaa-pfaiHZhI7Gje9DBch8e3hgYeYpiwkkZFbFukgtyv6VpZlygyvZtW_B_uuBw75-YKkEev2jLPdcHIKLB-10sV6umnwuOZ0md5f68Q-gSYTwCgWE_C5CEHFH74Q3ZQgwS7BaeQo_tkh70_iRz_M_cBWwm91H68jh8PoFtd1nvwAlPoWsWDZ6REjX63J7PN1VyfSI |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Sterile+immunogenic+non-tumorigenic+tumor+cell+compositions+and+methods&rft.inventor=Haspel%2C+Martin+V&rft.inventor=Pomato%2C+Nicholas&rft.inventor=Hanna%2C+Jr%2C+Michael+G&rft.number=7628996&rft.date=2009-12-08&rft.externalDBID=n%2Fa&rft.externalDocID=07628996 |